<DOC>
	<DOCNO>NCT01516424</DOCNO>
	<brief_summary>A Randomized , Double-blinded , Double-dummy , Parallel-controlled Multicenter Clinical trial Investigate Blonanserin Treatment Schizophrenia compare Risperidone</brief_summary>
	<brief_title>Efficiency Study Investigate Blonanserin Treatment Schizophrenia When Compared With Risperidone</brief_title>
	<detailed_description>A Randomized , Double-blinded , Double-dummy , Parallel-controlled Multicenter Clinical trial Investigate Blonanserin Treatment Schizophrenia compare Risperidone Trial drug : - Blonanserin group : Blonanserin tablets+Risperidone mimetic tablet - Risperidone group : Risperidone tablets+Blonanserin mimetic tablet Objectives Study : To evaluate efficacy safety Blonanserin treat schizophrenia</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Subject meet DSMIVTR criterion primary diagnosis schizophrenia Patients 18≤age≤65 year age day inform consent obtain . Subject PANSS total score ≥70 120≥ Screening Subject score ≥4 PANSS Screening Baseline . Subjects willing able comply study protocol include treatment hospital . Subjects legal guardian sign write informed consent form . The subject treatment Investigate product within 30 day . Subject history treatment longacting drug anti schizophrenia within 56 day . Subject history treatment clozapine within 28 day . Subject With parkinson disease , etc</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Blonanserin</keyword>
</DOC>